Select Page

Skin antiseptics for blood culture collection

Home Forums Infexion Connexion Skin antiseptics for blood culture collection

 | Click to Receive Email Notifications of Posts
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #68425
    Matthias.Maiwald@KKH.COM.SG Subject: Skin antiseptics for blood culture collection MIME-Version: 1.0 Content-type: text/plain; charset=US-ASCII Message-ID:
    Participant

    Author:
    Matthias.Maiwald@KKH.COM.SG Subject: Skin antiseptics for blood culture collection MIME-Version: 1.0 Content-type: text/plain; charset=US-ASCII Message-ID:

    Organisation:

    State:

    Dear Group,

    I would like to draw your attention to a small letter to the editor that we
    just published in ICHE:

    http://www.journals.uchicago.edu/doi/abs/10.1086/656561

    The original paper published a study of two skin antiseptics before blood
    culture collection and the impact in terms of blood culture contamination
    rates.

    The study describes itself as a trial of “chlorhexidine gluconate versus
    povidone-iodine”, and the contamination rate is significantly lower in the
    “chlorhexidine” group. However, the antiseptics used were 70% isopropanol
    plus 3.15% chlorhexidine versus aqueous povidone-iodine. In the text, the
    effect of lowering BC contamination rates is solely attributed to
    chlorhexidine. For reasons explained in our letter, there are very solid
    data in the literature that in this setting not the chlorhexidine but the
    alcohol is the key component in the disinfection process.

    This is an interesting misconception about chlorhexidine that I have seen
    previously in the US-based ClinMicroNet group and in the US literature. I
    am not sure why.

    Interestingly, the original authors respond by saying that it is not
    conclusive that the alcohol is the main component, however all 4 papers
    cited by them show either significant superiority or equivalence of
    alcohol-containing versus aqueous skin antiseptics.

    Best regards, Matthias.


    Matthias Maiwald, MD, FRCPA
    Consultant in Microbiology
    Department of Pathology and Laboratory Medicine
    KK Women’s and Children’s Hospital
    100 Bukit Timah Road
    Singapore 229899
    Tel. +65 6394 1389
    Fax +65 6394 1387

    —————————————————————————–
    The information contained in this e-mail or in any attachment is
    confidential and may be privileged. If you are not the intended recipient,
    you are not authorised to read, print, retain, copy, disseminate,
    distribute, or use this e-mail or any part thereof. If you receive this
    e-mail in error, please notify the sender immediately by e-mail and delete
    all copies of this e-mail. All opinions, conclusions and other information
    expressed in this e-mail that are not of an official nature shall not be
    deemed as given or endorsed by KK Women’s & Children’s Hospital.

    Insofar as this e-mail contains any medical opinion or advice, the medical
    opinion or advice is premised solely on the extent of medical information
    available to the writer of this e-mail and, where applicable, qualified by
    the lack of direct physical assessment and personal evaluation of the
    patient. Any medical opinion or advice expressed in this email does not
    necessarily represent the views of KK Women’s & Children’s Hospital.

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of AICA.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 1 post (of 1 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.